Prescription drug · BLA
Zaltrap (Ziv-aflibercept) NDC 0024-5840
Aflibercept 100 mg/4mL · Solution, Concentrate · Intravenous · sanofi-aventis U.S. LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0024-5840-01 | 0002458400100024584001 | 1 VIAL in 1 CARTON (0024-5840-01) / 4 mL in 1 VIALMarketed from Aug 3, 2012 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Zaltrap
- Generic name (nonproprietary)
- ziv-aflibercept
- Active ingredients
- Aflibercept — 100 mg/4mL
- Dosage form
- Solution, Concentrate
- Route
- Intravenous
- Labeler
- sanofi-aventis U.S. LLCNDC labeler code 0024
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 125418
- Marketing start
- Listing expires
- Other FDA classes
- Vascular Endothelial Growth Factor Inhibitors (Mechanism)
- Identifiers
- Product ID 0024-5840_14431dcb-cda7-4ae4-aa2b-6480d6ac459fSPL ID 14431dcb-cda7-4ae4-aa2b-6480d6ac459fSPL set ID f6725df6-50ee-4b0a-b900-d02ba634395dRxCUI 1723187, 1723189, 1723193, 1723194UNII 15C2VL427D
- Pharmacologic class
- Vascular Endothelial Growth Factor Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400024584001followed by a unit qualifier and the quantityPackage 00024-5840-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
ZALTRAP, in combination with fluorouracil, leucovorin, irinotecan-(FOLFIRI), is indicated for the treatment of patients with metastatic colorectal cancer (mCRC) that is resistant to or has progressed following an oxaliplatin-containing regimen. ZALTRAP, a vascular endothelial growth factor inhibitor, in combination with fluorouracil, leucovorin, irinotecan (FOLFIRI), is indicated for the treatment of patients with metastatic colorectal cancer that is resistant to or has progressed following an oxaliplatin-containing regimen. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 0024-5840
- What is NDC 0024-5840?
- 0024-5840 is the product NDC for Zaltrap (ziv-aflibercept), Aflibercept 100 mg/4mL solution, concentrate, listed with the FDA by sanofi-aventis U.S. LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Zaltrap (Ziv-aflibercept).
- What is the active ingredient?
- Aflibercept.
- Who is the labeler?
- sanofi-aventis U.S. LLC, NDC labeler code 0024. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Zaltrap?
- 1 other product NDC are listed under this name. See all Zaltrap NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Zaltrap products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Zaltrapziv-aflibercept | Aflibercept 200 mg/8mL | Solution, ConcentrateIntravenous | sanofi-aventis U.S. LLC | 0024-5841 | 00024-5841-01 |
Other NDCs under BLA 125418
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Zaltrapziv-aflibercept | Aflibercept 200 mg/8mL | Solution, ConcentrateIntravenous | sanofi-aventis U.S. LLC | 0024-5841 |